US Bancorp
KPRX icon

US Bancorp’s Kiora Pharmaceuticals KPRX Stock Holding History

US Bancorp’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$26 – 4295
2024
Q4 		$26 Hold
8
– – ﹤0.01% 4130
2024
Q3 		$29 Hold
8
– – ﹤0.01% 4050
2024
Q2 		$34 Buy
8
+1
+14% +$5 ﹤0.01% 3947
2024
Q1 		$47 Hold
7
– – ﹤0.01% 3935
2023
Q4 		$35 Hold
7
– – ﹤0.01% 3933
2023
Q3 		$38 Hold
7
– – ﹤0.01% 3953
2023
Q2 		$43 Hold
7
– – ﹤0.01% 3955
2023
Q1 		$224 Hold
7
– – ﹤0.01% 4014
2022
Q4 		$230 Hold
7
– – ﹤0.01% 4057
2022
Q3 		$0 Sell
7
-1
-13% -$78 ﹤0.01% 4146
2022
Q2 		$1K Hold
8
– – ﹤0.01% 3966
2022
Q1 		$2K Hold
8
– – ﹤0.01% 3837
2021
Q4 		$4K Hold
8
– – ﹤0.01% 3719
2021
Q3 		$6K Hold
8
– – ﹤0.01% 3588
2021
Q2 		$10K Hold
8
– – ﹤0.01% 3394
2021
Q1 		$13K Hold
8
– – ﹤0.01% 3195
2020
Q4 		$13K Hold
8
– – ﹤0.01% 3086
2020
Q3 		$11K Hold
8
– – ﹤0.01% 3050
2020
Q2 		$13K Hold
8
– – ﹤0.01% 3007
2020
Q1 		$14K Hold
8
– – ﹤0.01% 2902
2019
Q4 		$27K Hold
8
– – ﹤0.01% 2756
2019
Q3 		$9K Hold
8
– – ﹤0.01% 3083
2019
Q2 		$10K Hold
8
– – ﹤0.01% 3098
2019
Q1 		$12K Hold
8
– – ﹤0.01% 3007
2018
Q4 		$19K Hold
8
– – ﹤0.01% 2828
2018
Q3 		$13K Hold
8
– – ﹤0.01% 3037
2018
Q2 		$22K Hold
8
– – ﹤0.01% 2901
2018
Q1 		$15K Buy
+8
New +$34.6K ﹤0.01% 3030

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

US Bancorp's KPRX Position: Q1 2025 in Review

US Bancorp sold out of Kiora Pharmaceuticals (KPRX) in Q1 2025, closing a stake of 8 shares — an estimated $26 sold.

US Bancorp first reported a position in KPRX in Q1 2018 and held it in 28 quarters. The position peaked at $27K in Q4 2019. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2025.

  • US Bancorp reported no remaining Kiora Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 8 Kiora Pharmaceuticals shares in Q1 2025, an estimated $26.
  • US Bancorp first reported a position in Kiora Pharmaceuticals in Q1 2018 and held it in 28 quarters.
  • US Bancorp's Kiora Pharmaceuticals position peaked at $27K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.